...
首页> 外文期刊>Biochemical Pharmacology >Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones.
【24h】

Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones.

机译:噻二唑烷二酮对细菌二氢乳清酸脱氢酶的选择性抑制。

获取原文
获取原文并翻译 | 示例
           

摘要

Dihydroorotate dehydrogenase is a critical enzyme of de novo pyrimidine biosynthesis in prokaryotic and eukaryotic cells. Differences in the primary structure of the enzymes from Gram-positive and -negative bacteria and from mammals indicate significant structural divergence among these enzymes. We have identified a class of small molecules, the thiadiazolidinediones, that inhibit prototypical enzymes from Gram-positive and -negative bacteria, but are inactive against the human enzyme. The most potent compound in our collection functioned as a time-dependent irreversible inactivator of the bacterial enzymes with k(inact)/K(i) values of 48 and 500 M(-1) sec(-1) for the enzymes from Escherichia coli and Enterococcus faecalis, respectively. The data presented here indicate that it is possible to inhibit prokaryotic dihydroorotate dehydrogenases selectively while sparing the mammalian enzyme. Thus, this enzyme may represent a valuable target for the development of novel antibiotic compounds.
机译:二氢乳清酸脱氢酶是原核和真核细胞从头进行嘧啶生物合成的关键酶。来自革兰氏阳性和阴性细菌以及哺乳动物的酶的一级结构差异表明这些酶之间存在显着的结构差异。我们已经鉴定出一类小分子,噻二唑烷二酮,它们抑制革兰氏阳性和阴性细菌的原型酶,但对人类酶无活性。我们集合中最有效的化合物起着细菌酶的时间依赖性不可逆灭活剂的作用,大肠杆菌的酶的k(inact)/ K(i)值分别为48和500 M(-1)sec(-1)。和粪肠球菌。此处提供的数据表明,有可能选择性地抑制原核二氢乳清酸脱氢酶,同时保留哺乳动物的酶。因此,该酶可以代表开发新型抗生素化合物的有价值的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号